Overview

BrainCo is one of China’s leading BCI companies and among the first Chinese neurotech firms to achieve unicorn status. Founded in 2015 and headquartered in Hangzhou, the company develops non-invasive brain-computer interfaces for consumer, educational, and medical applications. BrainCo has been dubbed one of the “Six Little Dragons of Hangzhou” in the tech sector.

Product Portfolio

BrainCo operates across multiple BCI verticals. Its intelligent prosthetic hand uses EMG and EEG signals to provide dexterous motor control for amputees. The company also develops Focus, an EEG-based headband aimed at education and attention training, which has been deployed in Chinese schools and among US Olympic training programs.

Funding and IPO Path

BrainCo is seeking approximately $100 million in pre-IPO funding at a reported $1.3 billion valuation. The company has received significant backing from Zhejiang Province government funds, venture investors, and strategic partners. An IPO in Hong Kong or mainland China is under active preparation.

Strategic Position

As a rare commercial-stage Chinese BCI company with consumer products already on the market, BrainCo bridges the gap between laboratory research and mass-market neurotechnology. Its dual focus on prosthetics and consumer devices positions it for multiple revenue streams as the BCI market expands.